FDA's Top Vaccine Official Resigns Amid Criticism

Strategic Insights -

Vinay Prasad, the head of the division overseeing biological products at the US Food and Drug Administration (FDA), has left the agency just four months after his appointment. Prasad, an oncologist and professor at the University of California, San Francisco, was a fierce critic of US Covid-19 vaccine and mask mandates and had previously criticized the FDA. His departure has sparked concerns about the agency's credibility and decisions under his leadership.

Key Takeaways:

  • Prasad, the top vaccine official at the FDA, resigned after less than four months in the role, citing a desire to return to California and spend more time with his family.
  • He had been a fierce critic of US Covid-19 vaccine and mask mandates and, as director of the FDA's center for biologics evaluation and research, made several unusual regulatory decisions, including limiting the use of Covid-19 vaccines.
  • Prasad also held the additional role of the agency's chief medical and science officer, a position he was appointed to last month.
  • His resignation was met with a positive reaction from investors, with shares of Replimmune, Sarepta, and Capricor Therapeutics rising in premarket trading.
  • Biotech stocks initially plummeted when Prasad was appointed in May, but later recovered.
  • Prasad's critics argue that he was anti-patient choice, while his supporters argue that he was trying to reform the FDA's credibility.
  • Prasad's departure has sparked concerns about the agency's credibility and decisions under his leadership.

Statistics:

  • The Nasdaq Biotechnology Index declined 7% when Prasad was appointed in May.
  • Replimmune shares rose 58% in premarket trading after Prasad's resignation.
  • Sarepta shares increased 11.2% in premarket trading.
  • Capricor shares added 21.2% in premarket trading.
  • Prasad was appointed head of the FDA's center for biologics evaluation and research in May.

Sources:

  • Reuters: "Top US FDA vaccine official resigns after months of controversy"
  • Endpoints News: "FDA top vaccine official Vinay Prasad resigns"
  • STAT News: "FDA's top vaccine official resigns after just 4 months on the job"